Guardian Pharmacy Services, Inc.

For the period ended Jun 30, 2026. Filed Aug 6, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Aug 6, 2026

GRDN$47.02+10.9%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Statements of Operations

	Three Months Ended June 30,		Six Months Ended June 30,
(In thousands, except per share amounts)	2025	2026	2025	2026
Revenues	$344,334	$351,768	$673,642	$688,363
Cost of goods sold	276,188	271,724	541,147	532,010
Gross profit	68,146	80,044	132,495	156,353
Selling, general, and administrative expenses	55,566	59,400	106,910	118,034
Operating income	12,580	20,644	25,585	38,319
Other expenses (income):
Interest expense	172	154	342	308
Other expense (income), net	(179)	(9,302)	(450)	(10,074)
Total other expenses (income)	(7)	(9,148)	(108)	(9,766)
Income before income taxes	12,587	29,792	25,693	48,085
Provision for income taxes	3,760	7,671	7,593	12,420
Net income	8,827	22,121	18,100	35,665
Less net income (loss) attributable to non-controlling interests	(203)	249	(378)	498
Net income attributable to Guardian Pharmacy Services, Inc.	$9,030	$21,872	$18,478	$35,167
Basic	$0.15	$0.35	$0.30	$0.56
Diluted	$0.14	$0.34	$0.29	$0.55
Weighted-average Class A and Class B common shares outstanding
Basic	62,046	63,327	62,045	63,324
Diluted	63,203	63,836	63,055	63,757

See

Note 6 - Basic and Diluted Net Income Per Share

for the number of shares used in the computation of net income per share of Class A and Class B common stock and the basis for the computation of net income per share.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.